T1	Participants 95 141	hereditary androgenic alopecia in young males.
T2	Participants 370 418	young males with hereditary androgenic alopecia.
T3	Participants 463 529	alopecia with a mild to moderate perifollicular inflammation zone.
T4	Participants 553 685	20 subjects who received two tablets of ViviScal once daily and 20 who received two tablets of fish extract once daily for 6 months.
T5	Participants 686 749	The mean patient age and mean duration and severity of baldness
T6	Participants 788 873	Most patients had been treated with long-term topical 2% minoxidil for 1 year or more
T7	Participants 1101 1198	three patients withdrew from the study before the fourth month due to lack of therapeutic effect.
